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Tissue inhibitors of metalloproteinases (TIMPs) regulate extracellular matrix (ECM) degradation by matrix metalloproteinases (MMPs)
throughout embryogenesis. We examined lungs from TIMP3 null mice and found decreased bronchiole branching, enhanced activity of MMPs
and enhanced fibronectin degradation throughout lung development compared to controls. Activation of focal adhesion kinase (FAK) was also
reduced from embryonic days 12.5 through 14.5 in TIMP3 null lungs. Treatment with a synthetic MMP inhibitor, GM6001, in utero enhanced the
branching pattern in both wild type and null lungs accompanied by a restoration of fibronectin localization, signaling through FAK and epithelial
cell proliferation in null lungs. Direct down-regulation of FAK abundance in WT lung organ culture by siRNA targeting resulted in reduced
bronchiole branching, phenocopying the TIMP3 defect. We propose that enhanced MMP activity in the absence of TIMP3 interferes with focal
ECM proteolysis, perturbing the intracellular signaling necessary for correct pattern formation of the bronchiole tree during bronchiole branching
morphogenesis. Thus, TIMP3 can indirectly regulate epithelial cell proliferation via MMP inhibitory activity. While others have demonstrated this
function for MMPs, and there is in vitro evidence that TIMP3 controls proliferation, to our knowledge this is the first evidence of TIMP3
regulating proliferation in vivo.
© 2006 Elsevier Inc. All rights reserved.Keywords: TIMP; MMP; E-cadherin; ECM; FAK; Fibronectin; Bronchiole branching morphogenesis; Lung development; Epithelial–mesenchymal interactionsIntroduction
Murine lung development begins on embryonic day 9.5
(Ed9.5) as paired endodermal buds from the primitive foregut
invade into the surrounding mesoderm Ten Have-Opbroek,
1991). Beginning at Ed11.5, these buds enter into a period of
rapid growth and begin a series of cleft and bud formations in a
process termed bronchiole branching morphogenesis, resulting
in the formation of the prospective bronchiole tree (Ten Have-
Opbroek, 1991). Bronchiole branching morphogenesis depends
on interactions between the prospective bronchiole epithelium,
the surrounding mesenchyme and the specialized extracellular
matrix (ECM) structure, the basement membrane, which serves
as an interface between the two compartments (Alescio and
Cassini, 1962; Schuger, 1997). Specific ECM molecules,
including the multi-adhesive basement membrane protein fibro-⁎ Corresponding author. Fax: +1 519 661 3827.
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esis (Mollard and Dziadek, 1998; Roman, 1997; Sakai et al.,
2003). During lung bud outgrowth, there is a thinning of the
basement membrane and reduced amounts of FN at the tips of
the growing buds (Mollard and Dziadek, 1998; Roman and
McDonald, 1992). Further, accumulation of FN in presumptive
cleft forming regions is thought to regulate the formation of two
daughter branches from one lung bud (Affolter et al., 2003).
Loss of FN, or the inability to form a FN matrix in vitro, leads to
impaired bronchiole branching (Gill et al., 2003; Roman et al.,
1991; Sakai et al., 2003) indicating an essential function for FN
during murine lung morphogenesis.
Remodeling of the ECM is believed to result from a shift in
the balance between active matrix metalloproteinases (MMPs)
and their endogenous inhibitors, the tissue inhibitors of metal-
loproteinases (TIMPs; Baker et al., 2002; Vu and Werb, 2000).
Multiple MMPs and TIMPs are present in the developing lung
(Kheradmand et al., 2002; Nuttall et al., 2004) and the MMP/
TIMP balance is tightly regulated during bronchiole branching
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Either decreased levels of active MMPs (Kheradmand et al.,
2002) or decreased levels of TIMPs resulting in increased MMP
activity (Gill et al., 2003), lead to impaired bronchiole branching
morphogenesis both in vitro and in vivo. While MMPs have the
potential to exert many effects through cleavage of bioactive
molecules or shedding of receptors from the cell surface (Mott
and Werb, 2004; Parks et al., 2004), their classical role in ECM
degradation presumably has an essential function during lung
development. Impaired branching observed in developing lungs
in the absence of TIMP3 is accompanied by reduced FN
abundance (Gill et al., 2003), which could reflect enhanced
degradation mediated by increased MMP activity. While the
importance of FN in lung morphogenesis is certain, the specific
role of the MMP/TIMP balance in the regulation of FN distri-
bution and abundance remains to be determined.
Cells bind FN via integrins, predominantly integrin α5β1
(Pankov and Yamada, 2002), which serve to transduce signals
from the ECM into the cell. Binding of FN to integrins results in
the localization of focal adhesion kinase (FAK) to developing
focal adhesions followed by activation of FAK through auto-
phosphorylation of tyrosine 397 (Carragher and Frame, 2004;
Schaller and Parsons, 1994). FAK then interacts with multiple
downstream signaling pathways, including the phosphatidyli-
nositide 3-kinase (PI3K) and mitogen-activated protein kinase
(MAPK) pathways, to regulate cell functions such as cell migra-
tion, proliferation and differentiation (Danen and Yamada, 2001;
Parsons, 2003; Schaller and Parsons, 1994).
Epithelial cells of the prospective respiratory system undergo
tightly regulated proliferation as they invade into the surround-
ing mesenchyme during bronchiole branching morphogenesis
(Nogawa et al., 1998). The epithelial cells at the tips of invading
buds may have a higher rate of proliferation than epithelial cells
in the cleft forming regions (Mollard and Dziadek, 1998). This
difference in proliferation rates, however, is not evident until
after the bud has begun to form (Nogawa et al., 1998). Enhanced
proliferation allows the epithelial sheet to expand as the pros-
pective bronchiole tubes elongate and is regulated through a host
of cellular signals. Growth factors, such as members of the
fibroblast growth factor (FGF) family, have been implicated in
the interaction between the invading epithelium and the sur-
rounding mesenchyme and are capable of regulating prolifera-
tion in the developing lung (Minoo, 2000). This regulation
occurs through interaction with multiple signaling pathways
including the PI3K and MAPK pathways (Wang et al., 2005b).
Proliferation may also be regulated in the developing lung
through the deposition and degradation of ECM proteins like
FN, which are capable of enhancing proliferation in vitro (Han et
al., 2005; Nguyen et al., 2005). In addition, interactions between
the basement membrane and growth factors regulate the
localization of growth factor gradients and thereby the locali-
zation of proliferation (Sannes and Wang, 1997). Thus, prolife-
ration in the developing lung is a complex process that requires
multiple levels of regulation and the coordination of many
signaling pathways.
In light of the above information, we hypothesized that the
reduction in the abundance of FN previously detected in TIMP3null lungs (Gill et al., 2003) could result in defective signaling
through FAK and thus contribute to the reduced branching
observed. In the current study, we demonstrate that enhanced
degradation of FN in the developing lungs of TIMP3 null mice
leads to impaired ECM-cell signaling through FAK. This is
accompanied by a reduction in epithelial cell proliferation.
Addition of a low concentration of a synthetic inhibitor of
metalloproteinases (GM6001) in utero rescues bronchiole
branching morphogenesis as well as FN abundance, FAK
signaling and epithelial cell proliferation. Furthermore, we
provide evidence that FAK signaling is required for bronchiole
branching morphogenesis and that down-regulation of FAK
signaling ultimately leads to the impaired branching observed in
TIMP3 null lungs. These results highlight the necessity for tight
regulation of the MMP/TIMP balance during development and
also provide evidence in support of a novel role for TIMP3 in
regulation of ECM-cell signaling through FN and FAK and the
subsequent regulation of epithelial proliferation during bronch-
iole branching morphogenesis. While many papers have demon-
strated a role for MMPs in the regulation of cellular proliferation
via ECM modulation or growth factor activation (reviewed by
McCawley and Matrisian, 2001; Mott and Werb, 2004; Vu and
Werb, 2000), and there is in vitro evidence that TIMP3 controls
proliferation (Baker et al., 1998; Yang and Hawkes, 1992) to our
knowledge, ours is the first evidence of TIMP3 indirectly
regulating proliferation in vivo.
Materials and methods
Mice
A full description of the generation of the TIMP3 null mice used in this study
was reported by Leco et al. (2001). Animals were cared for in accordance with
protocols approved by the UWO Animal Care Committee, following the
guidelines of the Canadian Council on Animal Care. For these experiments, the
mutant allele was back-crossed eight generations onto the C57/Black6 strain of
mice for clone 7, and back-crossed seven times onto the C57/Black6 strain of
mice for the independently targeted clone 8. Mice were maintained and bred as
previously described (Gill et al., 2003) and the TIMP3 null line(s) used in each
experiment are identified in legends to figures. Pregnant dams were sacrificed in
order to retrieve embryonic lungs at the desired time points (Ed11.5 to 14.5), with
the day of discovery of a vaginal plug being considered Ed0.5. Lungs were either
placed into organ culture, snap frozen on dry ice for RNA or protein analysis or
fixed with PBS-buffered 4% paraformaldehyde for 3 h at 4°C, dehydrated
through an alcohol series and embedded in paraffin wax for sectioning.
GM6001 injections
Pregnant wild type (WT) and null dams were injected intraperitoneally with
carboxymethyl cellulose (CMC; Sigma-Aldrich) or 20 mg/kg GM6001
(3.33 mg/ml in CMC; Chemicon International) on both Ed11.5 and Ed12.5
(n=12 for each group). Dams were sacrificed on Ed13.5, the embryonic lungs
removed and either snap frozen on dry ice for protein analysis or fixed with 4%
PBS-buffered paraformaldehyde for 3 h at 4°C, photographed, then dehydrated
through an alcohol series and embedded in paraffin wax for sectioning.
Quantification of lung bronchiole branching plus/minus GM6001 in
utero
Images of fixed lungs were digitally captured using a SMZ1500 dissecting
microscope equippedwith aDXM1200 digital camera and accompanyingACT-1
software (Nikon Canada). The number of terminal buds around the periphery
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independent investigators who were blind as to the genotype and treatment.
Extent of peripheral terminal bronchiole branching in vivo at Ed13.5 was
expressed according to the following equation adapted from Schuger et al.
(1991): (TB experimental /TB WT CMC control)×100, where TB experimental
is the number of terminal buds in each experimental group. Images of the left
lobe were also digitally outlined and the area of the lobe calculated using
SimplePCI software (C*Imaging Systems, Compix, Inc.). A two-way ANOVA
with a Tukey's post hoc test was used to determine statistical significance.
Western blot analysis
Western blot analysis was performed on lung homogenates fromWTand null
lungs (Ed12.5 to Ed14.5) or Ed13.5 lungs treated in utero with either GM6001 or
CMC essentially as described (Gill et al., 2003) with the exception that the
protein extraction buffer contained 1× phosphatase inhibitor (Roche Diagnos-
tics). Antibodies used in these studies were directed against FN (1:10,000
dilution; DAKO Diagnostics; Catalogue Number A0245), focal adhesion kinase
(FAK; 1:500 dilution; Oncogene Research Products; Catalogue Number PC314),
FAK phosphorylated at tyrosine 397 (pFAK; 1:1000 dilution; Sigma-Aldrich;
Catalogue Number F7926), E-cadherin (1:2500 dilution; BD Biosciences;
Catalogue Number 610182), proliferating cell nuclear antigen (PCNA; 1:1000
dilution; Novocastra; Catalogue Number NCLPCNA) or glyceraldehyde-3-
phosphate dehydrogenase (GAPDH; 1:10,000 dilution; Helena Biosciences;
Catalogue Number ASM2032). Secondary antisera were either anti-rabbit or
anti-mouse conjugated to horseradish peroxidase (1:5000; Sigma-Aldrich).
Optical density of autoradiographic bands was determined using SimplePCI
software on a minimum of three independent blots. The control (WT sample for
each time point in a developmental series) was set to one and arcsine
transformation was performed on the data. A two-tailed, independent Student's
t test was used to determine significance between genotypes at each gestational
age.
Northern blot analysis
Northern blot analysis was performed as previously described (Leco et al.,
1994) on homogenates from WT and null lungs (Ed12.5, 13.5 and 14.5). Total
RNA (5 μg) was separated by electrophoresis, transferred to a nylon membrane
and hybridized sequentially with 32P-labelled E-cadherin, Fn and Gapdh
cDNA probes. Bands of interest were visualized by exposure to X-AR film and
the optical density of each band was determined as described above.
Protein degradation assay
Lungs from three Ed13.5 WT or null embryos were homogenized in
extraction buffer [50 mM Tris–Cl (pH 7.5), 150 mMNaCl and 1% Triton X-100
plus one EDTA-free proteinase inhibitor cocktail pill (Roche Diagnostics) per
10 ml buffer], sonicated for 2 s and protein concentration determined. Samples
(50 μg) were diluted in substrate buffer [50 mM Tris–Cl (pH 7.5), 5 mM CaCl2
and 5 μMZnCl2], incubated at 37°C for 3 h in the presence or absence of 10 mM
EDTA, then analyzed by Western blot for FN, E-cadherin and GAPDH as
described above. This experiment was repeated three times using embryos from
different litters.
Immunohistochemistry
Paraffin-embedded lung tissue sections (7 μm) were prepared for
immunohistochemistry as previously described (Gill et al., 2003). Sections
were incubated with either FN, pFAK or PCNA antisera or DAKO blocking
solution alone (negative control) overnight at 4°C. Signal on sections incubated
with FN antisera (1:100) were visualized with secondary antibodies conjugated
to horseradish peroxidase (1:200) andAEC substrate (ICNBiomedical), counter-
stained with Mayer's hematoxylin and mounted under Crystal Mount (Biomeda
Corp). Sections incubated with pFAK (1:100) or PCNA (1:100) were visualized
using secondary antibodies conjugated to rhodamine or FITC (1:200; Jackson
Laboratories) and counterstained with Hoechst nucleic acid stain (2.5 μg/ml;
Molecular Probes), or propidium iodide (0.5 μg/ml; Sigma-Aldrich). Sectionswere mounted with fluoroguard (Biorad) and a coverslip. Images were captured
with the E1000 upright microscope and the digital camera and software were
described above. Once set for a minimal signal with the negative control,
exposure times were kept constant for all subsequent images.
Primary lung cell co-culture
Lungs were removed from WT mouse embryos on Ed13.5 and placed into
serum-free BGJb medium (Invitrogen). Lungs (5–8 per experiment) were rinsed
in PBS, pooled and treated with trypsin twice for 15 min at 37°C, then pipetted
gently to generate a single cell suspension. After centrifugation at 400×g, cells
were resuspended in BGJb medium with 10% fetal calf serum (FCS; Invitrogen),
counted and plated in 6-well plates at 5.0×105 cells per well. Primary co-
cultures consisted of both epithelial and mesenchymal cells. After 18 h, the cells
were given fresh BGJb medium with 10% FCS 1 h prior to transfection with
siRNA.
The Fak siRNA sequence (sense: 5′-AACCACCUGGGCCAGUAUUAU-
3′; antisense: 5′-AUAAUACUGGCCCAGGUGG-3′) and the scrambled siRNA
sequence (sense: 5′-AAUUCUCCGAACGUGUCACGU-3′; antisense: 5′-AC-
GUGACACGUUCGGAGAA-3′) were based on a previous study (Duxbury et
al., 2003) and were purchased from Qiagen Inc. Double stranded RNA duplexes
(16 nM) were introduced into primary co-cultures using lipofectamine 2000
(Invitrogen) according to the manufacturer's guidelines. Cells were incubated
24 h, then either lysed with extraction buffer for Western blot analysis or fixed
with ice-cold methanol for immunohistochemistry. These experiments were
repeated 4 times with WT embryonic lung cells from different litters.
Primary cell co-cultures were prepared as above and after 18 h, transfected
with 1 μg of either an expression plasmid containing Fak cDNA or an empty
vector (gift from Dr. David Schlaepfer, Scripps Research Institute, La Jolla, CA)
using lipofectamine 2000. Cells were cultured in BGJb medium with 10% FCS
for 24 h and then lysed with extraction buffer or fixed with ice-cold methanol.
These experiments were repeated 3 times with lungs from different litters.
Primary cells were also cultured in 6-well plates in the presence of either
BSA or FN (1.3 μg/cm2; Sigma-Aldrich). Cells were cultured in BGJb medium
with 10% FCS for 24 h and then lysed with extraction buffer as described above.
This experiment was repeated 3 times with lungs from different litters.
Immunohistochemical analysis on primary cell co-cultures
Antibodies used were pan-cytokeratin antisera (1:250; DAKO-Z622),
PCNA antisera (1:100) or 0.5% normal lamb's serum alone (negative control).
Detection was achieved with secondary antibodies conjugated to horseradish
peroxidase (1:200) and AEC substrate. Ten random fields of view were captured
for each well using a TS100 tissue culture microscope equipped with the camera
and software described above (Nikon Canada) and immunostained cells were
counted by individuals blind to the treatment group. A two-tailed independent
Student's t test was used to determine significance.
Embryonic lung organ culture
Lung rudiments were removed fromWTand null mouse embryos on Ed11.5
and cultured as described (Gill et al., 2003). WT lungs from three separate litters
were transfected with either scrambled siRNA (16 nM; n=7) or Fak siRNA
(16 nM; n=5) using lipofectamine 2000. Peripheral terminal buds from the
entire lung were quantified at 72 h as described (Gill et al., 2003) and the lungs
fixed in ice-cold methanol.
Whole-mount immunofluorescence
Lungs from organ culture were incubated with pFAK antisera (1:100)
followed by anti-rabbit secondary antibody conjugated to rhodamine (1:200), or
E-cadherin antisera (1:200) followed by anti-mouse secondary antibody
conjugated to rhodamine (1:200), placed on a glass slide and covered with
fluoroguard (Biorad) and a coverslip. Images were captured using a Zeiss LSM
410 laser-scanning microscope and the accompanying Zeiss LSM software
package. Once set for a minimal signal with the negative control (secondary
antibody only), exposure times were kept constant for all subsequent images.
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GM6001 rescues bronchiole branching of TIMP3 null lungs in
vivo
We previously demonstrated that the loss of TIMP3 results in
impaired bronchiole branching morphogenesis, which can be
rescued in vitro by the addition of a low concentration of
GM6001, a synthetic inhibitor of metalloproteinases (Gill et al.,
2003). In the present study, we questioned whether GM6001
treatment would also rescue lung development in TIMP3 null
mice in utero. Pregnant dams were injected with carboxymethyl
cellulose (CMC, vehicle for GM6001) or GM6001 (20 mg/kg)
at Ed11.5 and Ed12.5, and embryonic lungs were harvested at
Ed13.5 for analysis. The number of peripheral terminal buds in
the left lung lobe from control TIMP3 null animals was reduced
significantly when compared to the left lung lobe from control
WT counterparts after injection of pregnant dams with CMC
(80% of WT, Fig. 1A and B). Injection of pregnant dams with
GM6001 led to a significantly enhanced branching pattern in
the embryonic lungs regardless of genotype. The number ofFig. 1. Impaired bronchiole branching of Ed13.5 TIMP3 null lungs is rescued by G
(b and d) left lung lobes at Ed13.5 after treatment with carboxymethyl cellulose (CM
dams with GM6001 leads to enhanced embryonic bronchiole branching (scale bar=20
the enhanced number of secondary buds around the periphery of the null lung treated
number of peripheral terminal bronchiole buds expressed as a percentage of the W
c, P<0.03; b vs. c, P<0.001). (C) Quantification of the area of the left lung lobe e
ANOVA; a vs. b, P<0.05). Data for this experiment were collected from both indepen
the two clones (CMC: WT, n=29 and null, n=22; GM6001: WT, n=26 and null, nterminal buds present in the GM6001 treated TIMP3 null left
lung lobe at Ed13.5 was similar to those observed in WT
controls (104% of WT, CMC control) and the number of buds
present in the WT animals treated with GM6001 was increased
above those observed in their vehicle control treated counter-
parts (112% of WT, CMC control; Figs. 1A and B). Images of
left lobes were also digitally outlined and the area of the tissue
calculated. The area of the left lung lobe from control TIMP3
null animals was reduced significantly when compared to the
left lung lobe from control WT counterparts (82% of WT, Fig.
1C). Injection of GM6001 tended to reduce the area of WT
lungs, and conversely increased the area of null lungs; however,
these results did not attain statistical significance (Fig. 1C).
Enhanced degradation of FN in lungs of TIMP3 null mice
In our earlier studies, FNwas the only ECMprotein examined
that was markedly decreased in embryonic TIMP3 null lungs
compared to WT (Gill et al., 2003). Here, we extended this
analysis with lungs from WT and null animals at Ed12.5, 13.5
and 14.5 (Fig. 2A). FN protein abundance was reduced at eachM6001 in utero. (A) Photomicrographs of whole-mount WT (a and c) and null
C; a and b) or GM6001 (c and d) at Ed11.5 and Ed12.5. Treatment of pregnant
0 μm). For clarity, the peripheral bronchiole branches are outlined in black. Note
with GM6001 (d) compared to the control null lung (b). (B) Quantification of the
T CMC treated lung set to 100% (two-way ANOVA; a vs. b, P<0.02; a vs.
xpressed as a percentage of the WT CMC treated lung set to 100% (two-way
dently derived clones (clone 7 and clone 8) with no difference observed between
=38; error bars represent±SEM).
Fig. 2. FN degradation is enhanced in embryonic TIMP3 null lungs during
bronchiole branching morphogenesis. (A) Western blot analysis for FN on lung
tissue homogenate from WT or TIMP3 mutant lungs at Ed12.5, Ed13.5 and
Ed14.5. (B) Densitometric ratio of FN protein abundance normalized for
GAPDH signal where WT is set to 100% for each time point. A statistically
significant reduction in FN abundance was observed at Ed12.5 and Ed 13.5
(*=significance P<0.006; two-tailed, independent Student's t test between
genotypes at each time point; n=3 from different litters; densitometry was
performed on a lesser exposure for all replicates). (C) Northern blot analysis of
WT and null lungs during lung development (Ed12.5, Ed13.5 and Ed14.5). The
values below the lanes represent a densitometric ratio of WT to null Fn mRNA
after normalization to Gapdh mRNA for the same gestational time point. Fn
mRNA abundance is higher in the null lung at Ed12.5 and Ed 13.5, as opposed
to FN protein abundance at the same time points. (D) Western blot analysis of
lung homogenate from Ed13.5WTand null lungs after incubation at 37°C in the
presence or absence of EDTA. A significant reduction in FN abundance was
observed between EDTA treatment (non-digested) and non-EDTA treatment
(digested) regardless of genotype (n=3 for each genotype and treatment; two-
way ANOVA; P<0.05).
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counterparts with a statistically significant reduction at Ed12.5
and 13.5 (Fig. 2B).To investigate whether this decrease in FN protein abundance
was a result of impaired synthesis or enhanced degradation, we
first employed Northern blot analysis. Fig. 2C demonstrates that
Fn mRNA abundance is actually higher in TIMP3 null lungs
compared to WT at both Ed12.5 and Ed13.5. Therefore, the
reduced FN protein abundance (Fig. 2A) is not due to reduced
Fn mRNA abundance.
We questioned whetherMMPs present in the developing lung
were capable of degrading endogenous FN protein. For this
analysis, Ed13.5 lungs from WT and TIMP3 null embryos were
homogenized and incubated for 3 h at 37°C in the presence or
absence of 10 mM EDTA (a metalloproteinase inhibitor) before
FN protein abundance was examined by Western blot. After 3 h
incubation, FN protein levels were significantly decreased in
both WT and null lung homogenate when compared to WT or
null samples incubated in the presence of EDTA indicative of FN
digestion by endogenous MMPs (Fig. 2D). Taken together, the
mRNA and protein degradation experiments demonstrate that
reduced FN protein abundance in the developing TIMP3 null
lung is mediated by metalloproteinase degradation of FN
protein, and not reduced Fn mRNA abundance in null lungs.
FN abundance is restored in embryonic TIMP3 null lungs by
GM6001
To determine if GM6001 could restore FN protein abun-
dance, we employed Western blot analysis of Ed13.5 WT and
null lung tissue from embryos treated in utero on Ed11.5 and
Ed12.5 with either GM6001 or vehicle (CMC). Treatment of
null embryonic lungwith GM6001 did indeed restore FN protein
levels to that seen in the WT lung. We next examined the
immunolocalization of lung FN at Ed13.5 after treatment with
GM6001 in utero. Examination of the tips of the developing
bronchioles at the lung periphery revealed a reduction in the
accumulation of FN in the absence of TIMP3 (Fig. 3B). In the
WT lung, FN immunoreactivity was present predominantly in
the basement membrane, in both cleft forming regions and to a
lesser extent at the tips of growing buds (Fig. 3B, panel a). FN
was also present at low levels throughout the WT lung
mesenchyme. Control, CMC injected TIMP3 null lungs had
far less immunostaining for FN (Fig. 3B, panel b). Treatment
with GM6001 increased the amount of FN in null lungs to levels
comparable to those present in the WT control, with a similar
distribution pattern (Fig. 3B, panel d vs. a). Therefore, a rescue
of FN accumulation in TIMP3 null lungs treated with GM6001
was clearly revealed by immunohistochemistry.
Impaired intracellular signaling downstream of FN in the
absence of TIMP3
To explore the effect of reduced FN abundance in the TIMP3
null lungs, we examined the abundance of phosphorylated focal
adhesion kinase (pFAK), which is a downstream target of FN-
integrin interactions. In the absence of TIMP3, pFAK abundance
was reduced during the initial stages of bronchiole branching
morphogenesis when compared to lungs from WTanimals (Fig.
4A). Densitometry confirmed that the quantity of pFAK was
Fig. 3. FN abundance is restored in embryonic null lungs treated in utero with GM6001. (A) Western blot analysis for FN on whole lung extracts from Ed13.5 WTand
null lungs treated for 2 days with either GM6001 or vehicle (CMC). FN protein abundance in null lungs exposed to GM6001 is restored to WT levels.
(B) Immunohistochemical analysis for FN (red stain) on Ed13.5 WT vs. null lungs plus/minus GM6001 treatment. FN is predominantly localized to the basement
membrane surrounding epithelial tubes, and diffusely localized throughout the mesenchyme of WT lung (a), reduced in the TIMP3 null lung (b) and restored to a
pattern similar to WT in a null lung after treatment with GM6001 in utero (d). The negative control (c) was treated with goat-anti-rabbit secondary antisera alone (scale
bar=50 μm). Data for these experiments were collected from both independently derived clones (clone 7 and clone 8).
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reduction at Ed12.5 and 13.5 compared to WT lungs (Fig. 4B).
Administration GM6001 in utero enhances FAK activation in
TIMP3 null lungs
The next question to address was whether enhanced FN
abundance in TIMP3 null lungs after treatment with GM6001
led to a rescue of FAK activation. Similar to FN, the abundance
of pFAK was rescued in null lungs treated with GM6001 as
demonstrated by Western blot analysis (Fig. 5A). pFAK immu-
noreactivity was localized to the basal aspect of the bronchiole
epithelial cells of WT lungs, but was virtually absent from
similar regions in null lungs (Fig. 5B, panel a vs. b). pFAK was
also diffusely localized throughout the WT lung mesenchyme,
consistent with the pattern we observed for FN (Fig. 5B, panel a
vs. Fig. 3B, panel a, respectively). Treatment with GM6001 in
utero led to increased accumulation of pFAK in epithelial cells ofbranching bronchioles and throughout the mesenchymal com-
partment of TIMP3 null lungs, restoring pFAK immuno-
reactivity to a pattern consistent with WT lungs (Fig. 5B,
panel d vs. a). Furthermore, the distribution of pFAK in epithelial
cells after rescue was coincident with the distribution of FN in
the basement membrane after rescue in the null lungs (Fig. 5B,
panel d vs. Fig. 3B, panel d).
E-cadherin abundance is reduced in the lungs of TIMP-3 null
mice
Others have shown that FN may regulate cleft formation in
the lung by altering E-cadherin cell–cell adhesions (Sakai et al.,
2003). We therefore hypothesized that in the TIMP3 null lungs,
the loss of FN and subsequent loss of epithelial cell FAK
signaling could result in a reduction of E-cadherin expression in
potential cleft forming regions with fewer branch points formed
in developing bronchioles. To explore this potential downstream
Fig. 4. Signaling through FAK is reduced in TIMP3 null lungs during bronchiole
branching morphogenesis. (A) Western blot analysis of embryonic mouse lungs
for pFAK and total FAK protein at Ed12.5, Ed13.5 and Ed14.5 demonstrating
reduced abundance of pFAK in TIMP3 null lungs compared to WT lungs at the
same gestational age. (B) Densitometric ratio of pFAK protein abundance
normalized for GAPDH signal where WT is set to 100% for each time point
(*=significance; two-tailed, independent Student's t test between genotypes at
each time point; P<0.02; n=3 for each time point; densitometry was performed
on a lesser exposure for all replicates).
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lungs by Western blot analysis with E-cadherin antisera. In a
pattern similar to both FN and pFAK abundance, E-cadherin
abundance was reduced throughout the early stages of branching
morphogenesis with a statistically significant reduction ob-
served at Ed12.5 (Figs. 6A and B). Northern blot analysis
demonstrated a reduction of E-cadherin mRNA abundance at
both Ed12.5 and 13.5 (Fig. 6C), reflective of what was observed
for E-cadherin protein.
In addition, MMPs are capable of cleaving the E-cadherin
protein (Xian et al., 2005; Covington et al., 2005). We therefore
examined if the reduction in E-cadherin abundance was due to
cleavage by MMPs present in TIMP-3 null lungs. Analysis of E-
cadherin protein in the in vitro degradation assay described
above revealed no digestion of the E-cadherin protein by MMP
(s) present in Ed13.5 lungs (Fig. 6D). The E-cadherin protein
was not cleaved after incubation of samples for as long as 24 h at
37°C (not shown), which indicates that the reduced E-cadherin
abundance in the TIMP-3 null lung is not due to metallopro-
teinase digestion.
FAK is required for bronchiole branching morphogenesis
To this point, there were correlative data supporting the
hypothesis that a reduction in FAK signaling may be responsiblefor the reduced branching observed in the TIMP3 null lung. We
tested this hypothesis directly utilizing siRNA down-regulation
of FAK expression in whole lung organ culture. Lungs from
Ed11.5 WT mice were cultured in the presence of either
scrambled siRNA or Fak siRNA for 72 h. Treatment of lungs
with Fak siRNA led to a significant 30% reduction in the
number of peripheral terminal bronchiole buds (Figs. 7A and B)
and an abnormal branching pattern compared to control lungs
treated with scrambled siRNA (Fig. 7A). Analysis by whole-
mount immunofluorescence demonstrated that the abundance of
pFAK was reduced in lungs treated with Fak siRNA (Fig. 7C,
panel c) when compared to control lungs (Fig. 7C, panel a).
Contrary to our expectation that direct down-regulation of pFAK
signaling would reduce E-cadherin protein levels, no difference
in E-cadherin abundance between the two treatment groups was
observed by immunofluorescence (Fig. 7C, panels b and d).
FAK signaling regulates epithelial cell proliferation
We next asked if reduced FAK activation could result in
decreased epithelial cell proliferation, which may contribute to
the reduced branching in the null lung. Here we utilized an
epithelial andmesenchymal primary cell co-culture from Ed13.5
WT lungs incubated in the presence or absence of Fak siRNA.
Down-regulation of FAK expression in monolayer cultures led
to a significant decrease in the number of cytokeratin immuno-
positive cells (epithelial cells) in the cultures (30% reduction in
Fak siRNA treated cultures compared to scrambled siRNA;
Figs. 8A and C). To investigate whether the reduced epithelial
cell number could be attributed to decreased proliferation,
siRNA treated cells were immunostained for proliferating cell
nuclear antigen (PCNA). Quantification revealed a significant
reduction of 50% in PCNA positive cells observed in cultures
treated with Fak siRNA compared to cultures exposed to
scrambled siRNA (Figs. 8A and C). Treatment of cells with Fak
siRNA led to a significant reduction in FAK protein abundance
compared to cells treated with scrambled siRNA as determined
byWestern blot analysis (Fig. 8B). Consistent with the reduction
in epithelial cell number in the cultures, Western blot analysis
revealed a significant reduction in E-cadherin protein abundance
in extracts from cells treated with Fak siRNA compared to
control (Fig. 8B).
We also performed complementary experiments, up-
regulating FAK signaling using two approaches. To determine
whether FN was involved in regulation of cell proliferation
through FAK activation, primary epithelial and mesenchymal
cells from Ed13.5 WT lungs were cultured on either BSA or
FN. Cells cultured on BSA or FN had similar levels of FAK
protein; however, the abundance of pFAK and PCNA was
significantly increased in cells cultured on FN vs. BSA (Fig.
8D). To confirm that these effects were a direct result of
increased FAK activation, primary co-cultures were transfected
with either empty vector or a Fak-expression vector. Co-
cultures transfected with the Fak-containing vector had
significantly increased abundance of FAK and pFAK, indicat-
ing that FAK was being over-expressed in these cells (Fig. 8D).
As a result of enhanced signaling through pFAK, PCNA
Fig. 5. Signaling through pFAK is rescued in embryonic lungs treated in utero with GM6001. (A) Western blot analysis for pFAK and total FAK protein on whole lung
extracts from Ed13.5 WT and null lungs treated for 2 days with either GM6001 or vehicle (CMC). pFAK protein abundance in null lungs exposed to GM6001 is
restored to WT levels. (B) Immunofluoresence analysis for pFAK on Ed13.5WT vs. null lungs plus/minus GM6001 treatment. pFAK is localized to the basal aspect of
the epithelial cells in WT lung and diffusely throughout the mesenchyme (a), reduced in the TIMP3 null lung (b) and restored to a pattern similar to WT in a null lung
after treatment with GM6001 in utero (d). The negative control (c) was treated with goat-anti-rabbit secondary antisera alone. These are serial sections to those used in
Fig. 2 (scale bar=50 μm). Nuclei were counterstained with Hoechst stain (blue) to show histology. Data for these experiments were collected from both independently
derived clones (clone 7 and clone 8).
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Western blot analysis (Fig. 8D). Immunohistochemical analysis
confirmed that there were significantly more cytokeratin
immuno-positive cells, and therefore a significantly enhanced
number of epithelial cells after over-expression of FAK (Fig.
8E). Consistent with the increased epithelial cells in cultures
over-expressing FAK, the amount of E-cadherin protein was
also significantly increased over cultures transfected with
empty vector (Fig. 8D).
Proliferation is reduced in the absence of TIMP3 in vivo
In monolayer culture, we demonstrated that loss or gain of
FAK expression led to reduced or enhanced proliferation ofepithelial cells. Since FAK activation is reduced in embryonic
TIMP3 null lungs, we examined if cell proliferation was also
affected by the loss of TIMP3. Immunostaining for PCNA
revealed that the number of proliferating cells was reduced in
TIMP3 null lungs compared to WT (Fig. 9A, panel b vs. a). A
reduction was observed in both the epithelial and mesenchymal
compartments, but quantification revealed that the reduction was
significant only for epithelial cells (Fig. 9B). Consistent with the
observations for FN and pFAK, TIMP3 null lungs treated with
GM6001 had significantly enhanced epithelial cell proliferation
when compared to null lungs treated with CMC (Fig. 9A, panel d
vs. b) comparable to that seen in WT lungs (Fig. 9A, panel d vs.
a; Fig. 9B). Thus, treatment of TIMP3 null lungs in utero with
GM6001 re-established FN and pFAK localization within the
Fig. 6. E-cadherin abundance is reduced during bronchiole branching in TIMP3
null mice. (A) Western blot analysis for E-cadherin on lung tissue homogenate
from WT or TIMP3 mutant lungs at Ed12.5, Ed13.5 and Ed14.5. (B)
Densitometric ratio of E-cadherin protein abundance normalized for GAPDH
signal where WT is set to 100% for each time point. A statistically significant
reduction in E-cadherin abundance was observed at Ed12.5 (*=significance
P<0.05; two-tailed, independent Student's t test between genotypes at each
time point; n=3 from different litters; densitometry was performed on a lesser
exposure for all replicates). (C) Northern blot analysis of WT and null lungs
during lung development (Ed12.5, Ed13.5 and Ed14.5). The values below the
lanes represent a densitometric ratio of WT to null E-cadherin mRNA after
normalization to Gapdh mRNA for the same gestational time point. E-cadherin
mRNA abundance is higher in the WT lung at Ed12.5 and Ed 13.5, consistent
with E-cadherin protein abundance at the same time points. (D) Western blot
analysis of lung homogenate from Ed13.5 WT and null lungs after incubation at
37°C in the presence or absence of EDTA. No significant differences in
E-cadherin protein abundance were noted±EDTA (n=3 for each genotype and
treatment). Data for these experiments were collected from both independently
derived clones (clone 7 and clone 8). An extended digestion time of 24 h did
not result in degradation of the E-cadherin protein (not shown).
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to that seen in the WT lung and rescued the branching defect
within null lungs.
Discussion
Lung morphogenesis is a dynamic process requiring cross-
talk between the epithelium, the basement membrane and the
surrounding mesenchyme, transmitted predominantly through
growth factors and their receptors (Cardoso, 2000). Further
interactions include the temporally and spatially regulated
deposition of specific ECM proteins (Mollard and Dziadek,
1998; Roman, 1997; Schuger, 1997), accompanied by remodel-
ing of the ECM by MMPs (Ganser et al., 1991; Gill et al., 2003;
Kheradmand et al., 2002). Although the role of ECM in lung
development has been well characterized, little is known about
the specific mechanism through which it fulfills this function.
Here, we provide evidence that FAK, and more specifically FN
signaling through FAK, is required for bronchiole branching
morphogenesis and that this signaling can be modulated by the
enzymatic activity of MMPs.
We previously reported that loss of TIMP3 in the developing
lung led to impaired bronchiole branching, and that this was
accompanied by increased MMP activity and a reduction in FN
protein abundance (Gill et al., 2003). Here we demonstrate that
the reduction in FN abundance in TIMP3 null lungs is due to
enhanced degradation of the FN protein by a TIMP3 sensitive
metalloproteinase. As a consequence, we conclude that TIMP3
indirectly, through inhibition of metalloproteinases, regulates
FN protein abundance in the developing lung. Furthermore, we
show that treatment of TIMP3 null lungs in utero with a broad
spectrum metalloproteinase inhibitor, GM6001, restored FN
protein abundance and localization, enhanced FAK signaling,
increased epithelial cell proliferation and rescued bronchiole
branching to levels comparable to the developing WT lung.
Therefore, we propose that TIMP3 normally functions to restrict
metalloproteinase activity, leading to proper ECM-cell signal-
ing through FN and FAK, ultimately resulting in proliferation of
the epithelial cells in developing bronchioles and proper
bronchiole branching morphogenesis.
In addition to measuring the extent of bronchiole branching,
we also calculated the area of the left lobe in control or GM6001
treated WT and TIMP3 null left lung lobes. Control null lungs
were found to be significantly smaller than control WT lungs.
These data support our hypothesis that, in the null lungs, en-
hanced MMP activity leads to reduced epithelial proliferation,
reduced bronchiole branching and therefore reduced total area of
the lung. Treatment ofWT lungs with GM6001 tended to reduce
the size of the lung suggesting that excessive inhibition ofMMPs
is detrimental to proper lung growth. Alternatively, treatment of
null lungs with the synthetic MMP inhibitor tended to increase
the size of null lungs such that they were not significantly
different fromWT.Moderation of excessiveMMP activity in the
null lungs by GM6001 enhances epithelial proliferation and
therefore restores both branching and size of the lung.
Our results with in utero GM6001 treatment differ from those
of Kheradmand et al. (2002), who found that addition of GM6001
Fig. 7. FAK signaling is required for bronchiole branching in whole cultured lungs. (A) Photomicrograph of WT lungs after 72 h cultured in the presence of either
scrambled siRNA (a; n=7) or Fak siRNA (b; n=5; scale bar=100 μm) demonstrating reduced branching in lungs exposed to Fak siRNA. (B) Quantification of the
number of terminal bronchiole branches expressed as the percentage of the scrambled siRNA treated lung (set to 100%; *=significance; two-tailed, independent
Student's t test; P<0.04; error bars represent±SEM). (C) Down-regulation of FAK signaling after siRNA treatment of lungs in organ culture was confirmed via
whole-mount immunofluorescent staining and confocal microscopy for pFAK. Lungs cultured in the presence of scrambled siRNAwere immuno-positive for pFAK
(a), while lungs cultured with Fak siRNA showed much less staining (c). Arrows indicate epithelial tubes of developing bronchioles. Down-regulation of FAK
signaling by siRNA treatment did not reduce the abundance of the E-cadherin protein in organ culture lungs (b and d).
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on Ed10.5 through Ed12.5. This apparent discrepancy can be
explained by the fact that we used five-fold less inhibitor in our
studies. That is, at the dose used in our studies (20 mg/kg),
GM6001 enhanced branching regardless of genotype, while at
high dose (100 mg/kg; Kheradmand et al., 2002), the synthetic
MMP inhibitor essentially blocked embryonic lung development.
This concept is further supported by our previous studies where a
low concentration of GM6001 added to cultured lung rudiments
augmented bronchiole branching, while at high concentration
GM6001 diminished branching (Gill et al., 2003). A potential
mechanism detailing the role of TIMP3 and MMPs in lung
branching morphogenesis is presented in Fig. 10.
To date, little work has been done to explore a specific
function for FAK during lung morphogenesis; however, circum-
stantial evidence indirectly supports a role for FAK in regulating
bronchiole branching. First, FAK is known to mediate ECM-cell
signaling. Following ECM-integrin interaction, FAK is localizedto focal adhesions within the cell and becomes autopho-
sphorylated at tyrosine 397, leading to an increase in catalytic
activity (Parsons, 2003; Schaller and Parsons, 1994). Second,
integrin and ECM proteins that are capable of activating the
FAK signaling pathway are required for bronchiole branching
morphogenesis. Specifically, loss of α3β1 integrin, FN or
laminin leads to impaired branching (Kreidberg et al., 1996;
Roman et al., 1991; Sakai et al., 2003; Schuger et al., 1990,
1991). In our study, direct evidence supporting a function for
FAK in murine lung morphogenesis was provided by treatment
of developing WT lungs in organ culture with Fak siRNA. The
impaired bronchiole branching observed as a consequence of
reduced FAK signaling phenocopies the TIMP3 null defect
previously observed in culture (Gill et al., 2003), and
establishes that FAK is required for murine bronchiole bran-
ching morphogenesis.
Evidence for the regulation of lung epithelial cell prolifera-
tion by differential FAK activation is provided by our monolayer
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cell co-culture, a reduction in FAK abundance by siRNA treat-
ment was accompanied by a significant reduction in PCNA-
positive cells and in epithelial cell number. Alternatively, cells
cultured on FN had significantly increased FAK activation
accompanied by a significant increase in PCNA abundance. Thesignificant increase in epithelial cell number after FAK over-
expression confirms a role for FAK in the control of epithelial
cell proliferation. Finally, although we did not test this directly,
siRNA-mediated down-regulation of FAK in lung organ culture
appears to reduce epithelial cell number coincident with the
reduced branching when compared to control lungs.
Fig. 9. GM6001 treatment in utero rescues epithelial cell proliferation in TIMP3 null lungs. (A) Immunofluorescent analysis for PCNA (green) of WT (a) and TIMP3
null (b and d) lungs after treatment with either CMC (a and b) or GM6001 (d). Arrows indicate examples of proliferating epithelial cells. The negative control (c) was
treated with goat-anti-rabbit secondary antisera alone. All sections were counterstained with propidium iodide (red; n=4 for both genotypes and treatments; scale
bar=50 μm). (B) Graphical representation of the number of WT (set to 100%) or TIMP3 null epithelial cells expressing PCNA after treatment with CMC or GM6001
(n=4 separate lungs analyzed for both genotypes and treatments; two-way ANOVA; P<0.02; *=significance; error bars represent±SEM). Data for these experiments
were collected from both independently derived clones (clone 7 and clone 8).
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demonstrated through two independent pathways, the MAPK
and PI3K-Akt pathways (Kling et al., 2002; Wang et al., 2005b),
both of which can be regulated through growth factor signaling
(Ammit and Panettieri, 2001). FAK is capable of signaling
through either of these pathways and thereby capable of parti-
cipating in the regulation of proliferation during lung morpho-
genesis (Slack-Davis et al., 2003; Yamamoto et al., 2003).
Preliminary experiments designed to investigate Erk activationFig. 8. FAK controls proliferation of lung epithelial cells in WT primary co-cultures. (
or PCNA (b and d) after treatment with either scrambled siRNA (a and b) or Fak siRN
cytokeratin positive cells (red stain) are evident in the Fak siRNA treated cultures. Mo
only one cell in the Fak siRNA treated field was positive for PCNA (arrow, d). (B) We
24 h in the presence of scrambled siRNA or Fak siRNA for FAK and E-cadherin
normalized for GAPDH signal demonstrating a significant reduction in abundance of
n=4). (C) Graphical representation of the number of cells positive for cytokeratin
(*=significance; two-tailed, independent Student's t test; P<0.02; error bars represen
or FN, or in the presence or absence of a Fak expression vector. Numbers below lane
signal where controls are set to one (*=significance; two-tailed, independent Stude
expressing cytokeratin after treatment with an empty vector (set to 100%) or a Fa
P<0.001; error bars represent±SEM; n=3).inWTand TIMP3 null lungs did not demonstrate differential Erk
activation in response to differential FAK signaling (SEG and
KJL unpublished data). Thus, the function of FAK in the
regulation of proliferation is not via the Erk pathway in our
system; however, FAK may regulate proliferation through inter-
action with the PI3K-Akt pathway.
We had originally postulated that activated FAK might be
directly regulating the expression of E-cadherin in the lung. In
this scenario, less activated FAK in the TIMP3 null lung couldA) Immunohistochemical analysis of primary lung cells for cytokeratin (a and c)
A (c and d; n=3 experiments from different litters; scale bars=250 μm). Fewer
st cells stain positive for PCNA in cultures treated with scrambled siRNA, while
stern blot analysis of primary lung epithelial and mesenchymal cells cultured for
. Numbers below lanes represent the densitometric ratio of protein abundance
both proteins (*=significance; two-tailed, independent Student's t test; P<0.03;
or PCNA after treatment with scrambled siRNA (set to 100%) or Fak siRNA
t±SEM; n=4). (D) Western blot analysis of cells cultured for 24 h on either BSA
s represent the densitometric ratio of protein abundance normalized for GAPDH
nt's t test; P<0.04; n=3). (E) Graphical representation of the number of cells
k-containing vector (*=significance; two-tailed, independent Student's t test;
Fig. 10. Moderate MMP inhibition stimulates bronchiole branching. (A) Enhanced metalloproteinase activity (TIMP3 KO) results in excessive matrix degradation
yielding dilated tubules with few cleft forming regions and a lower level of FN/pFAK-dependent epithelial cell proliferation than observed in WT lungs. (B) The
correct balance between the activity of MMPs and inhibition by TIMP3 in the WT lung yields a stable ECM and therefore correct signaling through FN/pFAK and
appropriate epithelial proliferation. In the developing WT lung, punctate areas of ECM deposition contribute to a greater number of cleft forming regions or branch
points of bronchioles. (C) Addition of low concentration GM6001 to the TIMP3 null lung in utero mimics the normal MMP inhibitory effect of TIMP3 and therefore
rescues both epithelial proliferation and branching. Addition of a low concentration of GM6001 to the WT lung prevents the normal clearing of ECM, enhancing the
number of focal ECM deposits forming branch points. (D) Addition of high concentration GM6001 to WT (or TIMP3 null) lungs in utero (Kheradmand et al., 2002;
KJL and SEG, unpublished observations) or in vitro (Gill et al., 2003) completely blocks MMP activity, the epithelial bud is not able to digest the ECM, and therefore
invasion of the bud into the mesenchyme is prevented.
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forming regions, resulting in fewer branch points and a
subsequent reduction in bronchiole branch numbers observed.
However, down-regulation of FAK signaling by siRNA in
whole lung organ culture, while decreasing bronchiole branch-
ing, did not reduce E-cadherin abundance measured by immu-
nofluorescence. Thus, the most plausible explanation for
reduced E-cadherin abundance in the TIMP3 null lung is as a
direct result of impaired proliferation observed in the bronchiole
epithelium. Less epithelial cells in smaller and fewer bronchi
within the developing TIMP3 null lungs (vs. WT lungs) would
logically lead to the decrease in E-cadherin abundance detected
by Western blot analysis. In support of this idea, primary lung
cell cultures treated with Fak siRNA demonstrated a reduction
in PCNA positive cells, a reduction in the total number of
epithelial cells in the cultures and a reduction in E-cadherin
abundance. Conversely, cells over-expressing FAK demonstrate
increased proliferation and hence, increased epithelial cell
number and increased E-cadherin abundance.
It is also known that FAK is involved in the regulation of cell
migration, but this function is dependent on cell type or on the
type of migration being examined (migration towards a chemo-
attractant vs. random migration). Genetic studies have demon-
strated reduced migration in FAK-deficient cells suggesting that
FAK is required for cell migration (Ilic et al., 1995). Conversely,
reduction of FAK through siRNA leads to a reduction in N-cadherin and an increase in random HeLa cell migration
(Schaller, 2004; Yano et al., 2004). In the MCF-7 breast cancer
cell line, inhibition of SHP-2 (a src homology two-containing
phosphotyrosine phosphatase that inactivates FAK) leads to an
increase in FAK activation and E-cadherin expression accom-
panied by a decrease in migration (Wang et al., 2005a).
Regardless of these seemingly contradictory results, all support
a role for FAK signaling in the regulation of cellular migration,
and aberrant cell migration in the developing lung has been
shown to disrupt branching (Shannon et al., 2003). Thus, it is
tempting to speculate that in the TIMP3 null lungs, down-
regulation of FAK signaling may lead to a disruption of either
epithelial cell invasion or collective migration of the epithelial
sheet during bronchiole branching morphogenesis.
Recent evidence has broadened the function of metallopro-
teinases beyond simple digestion of ECM molecules to include
activation or degradation of bioactive molecules such as growth
factors and their receptors (Mott and Werb, 2004; Parks et al.,
2004). We have not ruled out the possibility of aberrant growth
factor processing or signaling contributing to the anomalous
bronchiole branching in the TIMP3 null lung. However, our
examination of defective lung development in the TIMP3 null
embryo has identified ECM-cell signaling through FAK as a
vital aspect of branching morphogenesis, and maintenance of
the correct balance between active MMPs and TIMPs is a key
regulator of this signaling. We demonstrate here, by a
553S.E. Gill et al. / Developmental Biology 298 (2006) 540–554combination of in vivo and biochemical techniques, that MMPs
can degrade FN in the developing lung. While FN degradation
has been described in the TIMP3 null involuting mammary
gland, the net result in the mammary gland was an increase in
epithelial apoptosis (Fata et al., 2001). We tested for, but could
not detect, enhanced epithelial apoptosis in the null lung.
Conversely, we did detect a FN/pFAK-dependent reduction in
proliferation in vivo. Thus, our current model is that the absence
of TIMP3 in the developing lung leads to enhanced degradation
of FN, resulting in reduced ECM-cell signaling through FAK.
The reduction in FAK signaling decreases epithelial cell
proliferation, culminating in the impaired bronchiole branching
observed in TIMP3 null lungs (Fig. 10). Future experiments
will allow us to identify the downstream mediators of FAK
signaling in lung morphogenesis.
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